Literature DB >> 23380150

Immunomodulatory and hemagglutinating activities of acidic polysaccharides isolated from Combretum racemosum.

Igor A Schepetkin1, Koffi Kouakou, Ahoua Yapi, Liliya N Kirpotina, Mark A Jutila, Mark T Quinn.   

Abstract

Extracts of leaves of different species of the genus Combretum have been used historically to treat a variety of medicinal problems. However, little is known about the active components conferring therapeutic properties to these extracts. In the present studies, we evaluated biochemical properties and immunomodulatory activity of polysaccharides isolated from the leaves of Combretum racemosum. Water-soluble polysaccharides from leaves of C. racemosum were extracted and fractionated by DEAE-cellulose and Diaion HP-20 to obtain a Diaion-bound fraction, designated Combretum polysaccharide-acidic bound or CP-AB, which was eluted with methanol, and an unbound fraction, designated as CP-AU. Molecular weight determination, sugar analysis, and other physical and chemical characterization of the fractions were performed. Fraction CP-AU (mol. weight 5.0 kDa) contained type II arabinogalactan and had potent immunomodulatory activity, inducing the production of interleukin (IL)-1β, -6, -10, and tumor necrosis factor-α (TNF-α) by human peripheral blood mononuclear cells (PBMC) and MonoMac-6 monocytic cells. Likewise, intraperitoneal administration of CP-AU increased in vivo serum levels of IL-6 and monocyte chemoattractant protein-1 (MCP-1) in mice. CP-AU-induced secretion of TNF-α in PBMC was prevented by Toll-like receptor 4 (TLR4) antagonist LPS-RS. Treatment with CP-AU induced phosphorylation of Akt2, Akt3, GSK-3β, HSP27, mTOR, and all p38 MAPK isoforms (α, β, δ, and γ), as well as stimulation of AP-1/NF-κB transcriptional activity. In addition, CP-AU effectively agglutinated erythrocytes from several species, including human, mouse, and rabbit. In contrast, fraction CP-AB was inactive in all biological tests, including cytokine production and hemagglutination. These data suggest that at least part of the beneficial therapeutic effects reported for the water extracts of leaves from C. racemosum are due to modulation of leukocyte functions.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23380150      PMCID: PMC3647372          DOI: 10.1016/j.intimp.2013.01.015

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  55 in total

1.  An acidic polysaccharide of Panax ginseng ameliorates experimental autoimmune encephalomyelitis and induces regulatory T cells.

Authors:  Insun Hwang; Ginnae Ahn; Eunjin Park; Danbee Ha; Jie-Young Song; Youngheun Jee
Journal:  Immunol Lett       Date:  2011-04-15       Impact factor: 3.685

2.  RG-II from Panax ginseng C.A. Meyer suppresses asthmatic reaction.

Authors:  In Duk Jung; Hye Young Kim; Jin Wook Park; Chang-Min Lee; Kyung Tae Noh; Hyun Kyu Kang; Deok Rim Heo; Su Jung Lee; Kwang Hee Son; Hee-ju Park; Sung Jae Shin; Jong-Hwan Park; Seung-Wook Ryu; Yeong-Min Park
Journal:  BMB Rep       Date:  2012-02       Impact factor: 4.778

3.  Neutral polymers elicit, and antibodies to spectrin, band 4.1 protein and cytoplasmic domain of band 3 protein inhibit the concanavalin A-mediated agglutination of human erythrocytes.

Authors:  K N Pestonjamasp; N G Mehta
Journal:  Biochim Biophys Acta       Date:  1995-04-12

4.  Therapeutic effects of astragalus polysaccharides on inflammation and synovial apoptosis in rats with adjuvant-induced arthritis.

Authors:  Jun-Bing Jiang; Jian-Dong Qiu; Li-Hua Yang; Jun-Ping He; George W Smith; Hong-Quan Li
Journal:  Int J Rheum Dis       Date:  2010-10       Impact factor: 2.454

5.  A common pathway mediated through Toll-like receptors leads to T- and natural killer-cell immunosuppression.

Authors:  Ilan Vaknin; Liora Blinder; Lynn Wang; Roi Gazit; Elena Shapira; Olga Genina; Mark Pines; Eli Pikarsky; Michal Baniyash
Journal:  Blood       Date:  2007-11-08       Impact factor: 22.113

6.  Cytokine induction by pyrogens: comparison of whole blood, mononuclear cells, and TLR-transfectants.

Authors:  Robert Kikkert; Els R de Groot; Lucien A Aarden
Journal:  J Immunol Methods       Date:  2008-04-22       Impact factor: 2.303

Review 7.  Immunomodulatory dietary polysaccharides: a systematic review of the literature.

Authors:  Jane E Ramberg; Erika D Nelson; Robert A Sinnott
Journal:  Nutr J       Date:  2010-11-18       Impact factor: 3.271

8.  Autologous mixed lymphocyte responses in experimentally-induced arthritis of the Lewis rat.

Authors:  Brian Catchpole; Anne S Hamblin; Norman A Staines
Journal:  Autoimmunity       Date:  2002-03       Impact factor: 2.815

9.  Toll-like receptor-mediated activation of B cells and macrophages by polysaccharide isolated from cell culture of Acanthopanax senticosus.

Authors:  S B Han; Y D Yoon; H J Ahn; H S Lee; C W Lee; W K Yoon; S K Park; H M Kim
Journal:  Int Immunopharmacol       Date:  2003-09       Impact factor: 4.932

10.  The Tuber borchii fruiting body-specific protein TBF-1, a novel lectin which interacts with associated Rhizobium species.

Authors:  Emanuela Cerigini; Francesco Palma; Elena Barbieri; Michele Buffalini; Vilberto Stocchi
Journal:  FEMS Microbiol Lett       Date:  2008-05-23       Impact factor: 2.742

View more
  2 in total

1.  Immunomodulatory activity of polysaccharides isolated from Clerodendrum splendens: beneficial effects in experimental autoimmune encephalomyelitis.

Authors:  Koffi Kouakou; Igor A Schepetkin; SangMu Jun; Liliya N Kirpotina; Ahoua Yapi; Daria S Khramova; David W Pascual; Yury S Ovodov; Mark A Jutila; Mark T Quinn
Journal:  BMC Complement Altern Med       Date:  2013-06-28       Impact factor: 3.659

2.  The Effects of Different Purifying Methods on the Chemical Properties, in Vitro Anti-Tumor and Immunomodulatory Activities of Abrus cantoniensis Polysaccharide Fractions.

Authors:  Shaowei Wu; Xiong Fu; Margaret A Brennan; Charles S Brennan; Chen Chun
Journal:  Int J Mol Sci       Date:  2016-04-06       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.